Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
life sciences
national blog main
new york blog main
startups
4
×
biotech
boston blog main
melinta therapeutics
national top stories
new york top stories
san diego blog main
san diego top stories
san francisco blog main
biogen
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
deals
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
ipo
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
venture capital
What
medicines
4
×
announced
bio
covid
drug
ipo
roundup
therapeutics
acquisitions
activity
approvals
backs
bacteria
bets
biogen
biopharma
business
ceo
clamped
click
collabs
company
daniel
deal
delays
developing
digital
disease
economic
example
exited
fast
fda
field
fighting
gain
gilead
gilead’s
grabbed
help
Language
unset
Current search:
fda
×
startups
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum